KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
KO-2806-001
Phase 1 other active
Quick answer
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors for Pancreatic Ductal Adeno Carcinoma, Colorectal Cancer, Non- Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma is a Phase 1 program (other) at Kura Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kura Oncology
- Indication
- Pancreatic Ductal Adeno Carcinoma, Colorectal Cancer, Non- Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma
- Phase
- Phase 1
- Modality
- other
- Status
- active